| Revenue growth | Revenue grew 20% YoY, driven by Noida ramp-up and Lucknow maturity. |
|---|---|
| Margins | Consolidated EBITDA margin at 24.2%, impacted by early-stage Noida losses. |
| Demand visibility | Strong demand for tertiary care across UP, Bihar, and NCR regions. |
| Management confidence | Balanced and highly confident in clinical execution and expansion roadmap. |
Growth
Revenue grew 20% YoY to ₹45,089 million; EBITDA grew 19% excluding Noida losses. Quality is high, volume-led.
Outlook
Adding 500 beds to existing facilities and 2,700 beds via five greenfield projects by FY30.
Risks
Intense clinical talent competition in Gurgaon and initial operating losses from the aggressive new hospital pipeline.
Earnings Call filed with BSE, NSE: MEDANTA. Summary written with AI assistance from the document.
Global Health Ltd: key numbers
- Share price
- ₹1,450.00
- Market cap
- ₹38,987 Cr
- Revenue (annual)
- ₹4,410 Cr
- Net profit (annual)
- ₹556.5 Cr
- P/E (TTM)
- 63.0×Sector 54.5×
- Promoter holding
- 33.00%+0.00% QoQ
- FII holding
- 9.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Health Ltd
All →Global Health Earnings Call Transcript: Key Takeaways
Global Health delivered strong results driven by high-occupancy and scale-up at Noida. Expansion remains aggressive with a new 500-bed Ghaziabad project.
Global Health Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 14,690m (+33.6%), Operating EBITDA INR 3,701m (25.2% margin), PAT INR 2,191m (+38.3%). Volume-led growth; net cash INR 7,815m.
Global Health Results Update
Global Health reported Q2 FY27 revenue of INR 14,690 million, up 33.6%, and PAT of INR 2,191 million, up 38.3%. Board approved a 500-bed Ghaziabad hospital.
Global Health Capacity Expansion: ₹997 Cr Investment
Medanta plans a 500-bed Ghaziabad hospital over 3-4 years. Project cost is Rs 997 Crore, funded by internal accruals and debt.
- Value
- ₹997.0 Cr
- Execution
- 3-4 years, phased
- hospital beds
- 500.0 beds
Global Health Q2 FY27 Results: Net Profit ₹219.1 Cr, Up 38.3% YoY
Global Health Ltd reported revenue from operations of ₹1,469 Cr (+33.6% YoY) and net profit of ₹219.1 Cr (+38.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹219.1 Cr · +38.3% YoY
Global Health Employee Stock Options
Global Health granted 3,14,000 ESOPs to 45 employees at ₹635 under LTIP 2024. Its Senior VP & Head-HR also resigned, effective 23 December 2026.